coptis japonica rhizome extract은 임신 중 안전한가요?
Coptis japonica rhizome extract (CAS 223748-66-1) is listed in the EU cosmetic ingredients list (Cosmetic Directive publication) as a permitted botanical extract with no Annex II ban or Annex III restriction; no harmonised CLP reproductive (H360/H361) or CMR classification was found. Large epidemiology on related Coptis/Coptidis rhizoma used orally showed no clear adverse effect on fetal growth at usual use, and mutagenicity testing of Coptis rhizome extracts did not indicate strong genotoxicity across standard assays. Given lack of reproductive/teratogenic animal or harmonised hazard data, hazard (h) and mechanism (m) are scored 0. Topical exposure is scored as low but measurable (e=1) because botanical extracts can deliver small amounts of phytochemicals through skin but no specific dermal absorption data were found.
Related ingredients
Frequently asked questions
- coptis japonica rhizome extract은 임신 중 안전한가요?
- Coptis japonica rhizome extract (CAS 223748-66-1) is listed in the EU cosmetic ingredients list (Cosmetic Directive publication) as a permitted botanical extract with no Annex II ban or Annex III restriction; no harmonised CLP reproductive (H360/H361) or CMR classification was found. Large epidemiology on related Coptis/Coptidis rhizoma used orally showed no clear adverse effect on fetal growth at usual use, and mutagenicity testing of Coptis rhizome extracts did not indicate strong genotoxicity across standard assays. Given lack of reproductive/teratogenic animal or harmonised hazard data, hazard (h) and mechanism (m) are scored 0. Topical exposure is scored as low but measurable (e=1) because botanical extracts can deliver small amounts of phytochemicals through skin but no specific dermal absorption data were found.
- coptis japonica rhizome extract은 모유 수유 중 안전한가요?
- No evidence of a reproductive or lactation hazard, no harmonised classifications, and no human data showing transfer via breastmilk for cosmetic topical use. Exposure considered low but measurable (e=1) for adult topical use in absence of dermal absorption data.
- coptis japonica rhizome extract은 아기 피부에 안전한가요?
- No infant-specific toxicity or developmental hazards were identified. Per scoring rules, exposure for 0–3 yr skin is increased by +1 over adult when the ingredient has measurable absorption: adult e=1 → baby e=2. There is no direct evidence to increase hazard (h) or mechanism (m) for infants.
- VeriMom은 coptis japonica rhizome extract을 어떻게 평가하나요?
- VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 coptis japonica rhizome extract을 93/100 (알려진 위험 없음)로 평가합니다.
- 임신 중 coptis japonica rhizome extract 대체 안전 성분은?
- 유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.
모든 성분표를 2초 만에 확인
VeriMom 무료 다운로드 — 어떤 제품이든 스캔해 임신 중 안전 점수를 즉시 확인하세요.
의료 면책 조항
이 정보는 교육 목적으로만 제공되며 의학적 조언을 구성하지 않습니다. 안전 점수는 공개적으로 이용 가능한 데이터를 기반으로 하며 모든 위험을 반영하지 않을 수 있습니다. 임신 중 또는 수유 중 제품을 사용하기 전에 항상 의료 전문가와 상담하십시오.